Author's posts
The Road To Population Health Is Paved With Good Intentions, But New Data Shows Old Fears Still Slowing The Journey
The voyage to population health is still very much a “Tale of Two Cities,” as executives’ expectations both in terms of being prepared to assume risk and actually taking on risk have failed to materialize in a big way. So, why aren’t organizations livi…
Our Nation’s Chronic Disease Epidemic Is Getting Worse So, Who’s Responsible?
Clearly, we have a healthcare epidemic on our hands. So, what’s the problem? For those living with chronic conditions, a fractured U.S. healthcare delivery system that prioritizes profits over patient outcomes has left them in the lurch.
If Pharma Companies Don’t Overhaul Their R&D Model Quickly, Cancer Patients In Desperate Search For New Cures Will Be Left Behind
The pharma industry’s global reach and scale is unparalleled. What’s at stake here isn’t just corporate profitability, but access to trials to improve the quality and duration of life for patients desperately in search of new cures.
Pharma Executives Are Awakening To A New Reality: Embrace The Future Of The Commercial Model Now Or Else
For sales force leaders, the economic pressures of this new landscape can be daunting. Some major drug companies have already started layoffs and we expect that trend to continue in a big way – especially as the number of and qualifications required fo…
In Our Flawed Healthcare System, Patients Need To Take More Control
Real reform begins by changing expectations. By doing so, we can introduce more accountability into each transaction between patients and their healthcare providers and set up the conditions needed to get better health at lower cost.
How The CDC Can Restore Trust And Credibility
The CDC has an opportunity to dramatically change the culture that has proven so ineffective and caused such distrust among Americans. Because of their essential public safety role, the need for change is an urgent one.
For The CDC, The First Step To Recovery Won’t Be The Hardest
Walensky’s statement and the desire to radically improve guidance for the future have to be seen as a positive first step. The efforts, however, must be long-term.
The Inflation Reduction Act: Death By A Thousand Cuts For The Drug Industry Begins In Earnest
This latest government intervention joins thousands of others that have added more and more complexity to a healthcare system that is visibly failing. In the end, the countless regulations that stifle innovation and indefinitely postpone real reforms i…
A Predictable Surprise: Twelve Years After Obamacare And We Are Worse Off Than Ever
In a recent analysis from the Commonwealth Fund, the U.S. ranked last on measures relating to access to care, administrative efficiency, equity, and overall health care outcomes, even though we devote nearly twice as much of our GDP as the average OECD…
Will Amazon’s Foray Into The Primary Care Market Be A Wake-Up Call Or A Torpedo For Legacy Health Systems?
Amazon’s latest move is poised to not only reduce the hide-and-seek aspects of acquiring basic health care today, but also significantly alter the primary care landscape through increased access to in-home services with a patient-centered focus.
